Answers are grounded in this paper and cite their sources.
Exogenous supplement of recombinant human (rh)ACE-2 might be a brilliant idea in the treatment of COVID-19. Soluble ACE-2 might impact viral spread, since binding to soluble receptor has been shown to block SARS-CoV-2 entry.https://bit.ly/3bsUKO2
No takes yet. Share an insight, caveat, or question.
Dhamend Lutchman (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: